Why is "Congenital hyperinsulinism" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-08-30 04:35:09
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Congenital_hyperinsulinism entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-08-30 and was most recently seen on 2026-08-30.
Wikipedia Overview
Congenital hyperinsulinism (HI or CHI) is a condition causing severe hypoglycemia in newborns due to the overproduction of insulin. There are various causes of HI, some of which are known to be the result of a genetic mutation. Sometimes HI occurs on its own (isolated) and more rarely associated with other medical conditions.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Rezolute’s Ersodetug Misses Congenital Hyperinsulinism Primary Endpoint - The Clinical Trial Vanguard
-
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism - Crinetics
-
The effect of hypoglycaemia on neurodevelopment: insights from congenital hyperinsulinism - Nature
-
Beyond BRUE (Brief Resolved Unexplained Event): Recurrent Unexplained Events Revealing Congenital Hyperinsulinism in Infancy - Cureus
-
Hanmi’s once-weekly hyperinsulinism drug advances in global phase 2 - Korea Biomedical Review
-
Ersodetug misses primary endpoint in phase 3 sunRIZE trial for congenital hyperinsulinism - Contemporary Pediatrics
-
Congenital Hyperinsulinism Treatment Market - Future Market Insights
-
FDA is still reviewing Rezolute’s experimental drug. No timeline is set. - Stock Titan
-
Ersodetug misses primary endpoint, but may raise glucose in congenital hyperinsulinism - Healio
-
Rezolute, Inc. Announces Four Presentations at the 2026 Annual Meeting of the Endocrine Society on Ersodetug for Congenital Hyperinsulinism - Quiver Quantitative
-
Congenital Hyperinsulinism: Oliver’s Story - Children's Hospital of Philadelphia
-
Focal form of congenital hyperinsulinism in a newborn diagnosed with 18F-DOPA PET/CT allows laparoscopic surgical approach - www.elsevier.com
-
This Glen Ridge Mom Founded an International Rare-Disease Organization After Her Son's Diagnosis - New Jersey Monthly
-
Rezolute (RZLT) Is Down 82.7% After Phase 3 sunRIZE Failure in Congenital Hyperinsulinism Trial - Yahoo Finance
-
Rezolute shares plunge on disappointing Phase 3 congenital hyperinsulinism trial results - Proactive financial news
-
Clinical Presentation and Molecular Characteristics of Kabuki Syndrome With Congenital Hyperinsulinism: A Retrospective Study - Cureus
-
From Isolation to Support: A Parent’s Journey with Congenital Hyperinsulinism - Springer Nature Link
-
US FDA grants breakthrough status to Hanmi drug for congenital hyperinsulinism - CHOSUNBIZ - Chosunbiz
-
FDA grants breakthrough status to Hanmi’s congenital hyperinsulinism drug - Korea Biomedical Review
-
Connecting, Learning and Growing Together at the 2025 HI Family Conference - Children's Hospital of Philadelphia
-
Why two Bay Area companies' stocks tumbled on a drug's clinical failure - The Business Journals
-
Chromosome 20p11.2 deletions cause congenital hyperinsulinism via the loss of FOXA2 or its regulatory elements - Nature
-
Congenital Hyperinsulinism International: A Community Focused on Improving the Lives of People Living With Congenital Hyperinsulinism - Frontiers
-
Congenital Hyperinsulinism: Dominique’s story - Children's Hospital of Philadelphia
-
Generations of Strength: Kristen’s Journey with Congenital Hyperinsulinism - Children's Hospital of Philadelphia
-
68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism - Journal of Nuclear Medicine
-
18F-FDOPA PET imaging in Congenital Hyperinsulinism for localization of a Focal Pancreatic Lesion: Do medications interfere with radiotracer uptake? - Journal of Nuclear Medicine
-
Neonatal Congenital Hyperinsulinism: A Case-Based Contribution to the Understanding of a Rare Disorder - Cureus
-
FDA Issues Second CRL for Dasiglucagon (Zegalogue) in Congenital Hyperinsulinism - HCPLive
-
Adjuvant Alpelisib Therapy for Congenital Hyperinsulinism - NEJM
-
Stem Cell Based Models in Congenital Hyperinsulinism – Perspective on Practicalities and Possibilities - Frontiers
-
Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus - Frontiers
-
Congenital hyperinsulinism in clinical practice: From biochemical pathophysiology to new monitoring techniques - Frontiers
-
Sidra Medicine conducts paediatric congenital hyperinsulinism trial - Clinical Trials Arena
-
Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism - Crinetics
-
Dasiglucagon Gets Priority Review for Hypoglycemia in Congenital Hyperinsulinism - empr.com
-
What is Congenital Hyperinsulinism? The rare genetic condition affecting Thomas Jacob Sanford’s son | Hindustan Times - hindustantimes.com
-
Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9 | Scientific Reports - Nature
-
A novel glucagon analog with an extended half-life, HM15136, normalizes glucose levels in rodent models of congenital hyperinsulinism - Nature
-
Non-coding variants disrupting a tissue-specific regulatory element in HK1 cause congenital hyperinsulinism - Nature
-
Congenital hyperinsulinism—A case of mild hypoglycemia in an adult, detected by family testing - Wiley Online Library
-
Disrupted β-cell-specific gene silencing causes congenital hyperinsulinism - Nature
-
Dasiglucagon Reduces Glucose Requirements in Congenital Hyperinsulinism Trial - empr.com
-
Case report: Pylorus-preserving pancreatoduodenectomy for focal congenital hyperinsulinism in a 5-month-old baby - Frontiers
-
18F-6-Fluoro-l-Dopa PET/CT Imaging of Congenital Hyperinsulinism - Journal of Nuclear Medicine
-
Case report: A novel HNF1A variant linked to gestational diabetes, congenital hyperinsulinism, and diazoxide hypersensitivity - Frontiers
-
Predicting the outcome for newborns with congenital hyperinsulinism - healthcare-in-europe.com
-
Cook Children’s Hyperinsulinism Center Named a Center of Excellence - checkupnewsroom.com
-
Laparoscopic Surgery for Focal-Form Congenital Hyperinsulinism Located in Pancreatic Head - Frontiers
-
Congenital Hyperinsulinism and Beckwith-Wiedemann Syndrome: Alina’s Story - Children's Hospital of Philadelphia
-
Can Surgery Cure Congenital Hyperinsulinism? - HCPLive
-
Eiger Announces FDA Breakthrough Therapy Designation for Avexitide for Treatment of Congenital Hyperinsulinism - PR Newswire
-
Three Generations Under CHOP’s Care for HI - Children's Hospital of Philadelphia
-
Hyperinsulinism/Hyperammonemia: Daniel’s Story - Children's Hospital of Philadelphia
-
Navigating Continuous Dextrose and Nutrition for Children with HI - Children's Hospital of Philadelphia
-
CHOP Doctor Awarded the Congenital Hyperinsulinism International "Be My Sugar" Award for Medical Excellence - PR Newswire
-
Health-Related Quality of Life of Children and Adolescents With Congenital Hyperinsulinism – A Scoping Review - Frontiers
-
Diabetic Medicine | Diabetes UK Journal - Wiley Online Library
-
Managing congenital hyperinsulinism: improving outcomes with a multidi | RRED - Dove Medical Press
-
Noncoding Variants Switch on "Disallowed" Regulatory Gene in Pancreas to Cause Rare Disease - Genetic Engineering and Biotechnology News
-
Diffuse Hyperinsulinism: Omar’s Story - Children's Hospital of Philadelphia
-
A Chaotic Symphony: Managing Three Kids with HI - Children's Hospital of Philadelphia
-
Amylyx Pharmaceuticals Acquires Phase III-Ready GLP-1 Receptor Agonist Avexitide for Hyperinsulinemic Hypoglycemia from Eiger BioPharmaceuticals - PharmExec.com
-
The Long Journey to Finding a Treatment that Works: Dante's Story - Children's Hospital of Philadelphia
-
Pioneers in Hyperinsulinism: Yesterday, Today and Tomorrow - Children's Hospital of Philadelphia
-
Two Days Too Late: How a Missed Diagnosis Changed a Family’s Life Forever - Jewish Journal
-
Cook Children's Hyperinsulinism Center Wins International Award - Fort Worth Inc.
-
Hyperinsulinism and Turner Syndrome: Aliza’s Story - Children's Hospital of Philadelphia
-
HI Can’t Stop Abigail’s Big Dreams - Children's Hospital of Philadelphia
-
Dr. Diva De León-Crutchlow, Pediatric Endocrinologist at Children's Hospital of Philadelphia, Honored by Congenital Hyperinsulinism International - PR Newswire
-
Hyperinsulinism Advocate Extraordinaire: Kaylee and Kathleen's Story - Children's Hospital of Philadelphia
-
Dr. Stanley’s Pioneering Career Recognized - Children's Hospital of Philadelphia
-
FDA declines to approve Zealand Pharma’s hypoglycaemia therapy in infants - Pharmaceutical Technology
-
A new approach to high insulin levels - EurekAlert!
-
Rezolute targets $90 million fundraise after positive late-stage trial news - San Francisco Business Times - The Business Journals
-
Hyperinsulinism, LINE Type: Paige’s Story - Children's Hospital of Philadelphia
-
Hyperinsulinism: It’s Not Transient Neonatal Hypoglycemia - Children's Hospital of Philadelphia
-
Hyperinsulinism/hyperammonemia Syndrome: Adam’s Story - Children's Hospital of Philadelphia
-
Focal congenital hyperinsulinism in a patient with septo-optic dysplasia - Nature
-
Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism - Nature
-
Rhythm Pharmaceuticals BV acquires Amsterdam’s Xinvento to develop therapies for congenital hyperinsulinism - Silicon Canals
-
Baby with congenital disorder needs PHP 17 Million for life-saving operation - Cebu Daily News
-
Rezolute Appoints Davelyn Hood, MD as Director - citybiz
-
Babies born with congenital hyperinsulinism (CHI) are at risk of suffering from permanent brain damage - debuglies.com
-
Hyperinsulinaemic hypoglycaemia in children and adults - thelancet.com
-
Congenital hyperinsulinism - medtalks.in
-
Sidra Medicine pioneers groundbreaking treatment protocol for infant with congenital hyperinsulinism - The Peninsula Qatar
-
Sidra Medicine conducts first clinical trial for pediatric congenital hyperinsulinism - The Peninsula Qatar
-
Amazing picture shows how treatment for six-year-old Sophie's disease makes her hair grow long - Manchester Evening News
-
'Real-life Rapunzel': Girl's long blonde hair grows super fast because of drug she takes for rare disease - The Mirror
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.